Zobrazeno 1 - 10
of 3 025
pro vyhledávání: '"Siurala, M."'
Autor:
Watanabe K; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.; Division of Cancer Immunology, National Cancer Center Research Institute, Tokyo, Japan., Gomez AM; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Kuramitsu S; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Siurala M; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Da T; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Agarwal S; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Song D; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Rotolo A; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA., Posey AD; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA.; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA., Rook AH; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Haun PL; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Ruella M; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Young RM; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Publikováno v:
Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3416-3430.
Autor:
Kalbasi A; Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. anushakalbasi@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. anushakalbasi@mednet.ucla.edu., Siurala M; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Su LL; Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Tariveranmoshabad M; Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Picton LK; Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Ravikumar P; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Li P; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Lin JX; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Escuin-Ordinas H; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Da T; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kremer SV; Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Sun AL; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Castelli S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Agarwal S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Song D; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rommel PC; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Radaelli E; Penn Vet Comparative Pathology Core, Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Young RM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Leonard WJ; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Ribas A; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. aribas@mednet.ucla.edu.; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu., June CH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cjune@upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu., Garcia KC; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. kcgarcia@stanford.edu.; Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. kcgarcia@stanford.edu.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. kcgarcia@stanford.edu.; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA. kcgarcia@stanford.edu.
Publikováno v:
Nature [Nature] 2022 Dec; Vol. 612 (7938), pp. E10.
Autor:
Kalbasi A; Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. anushakalbasi@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. anushakalbasi@mednet.ucla.edu., Siurala M; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Su LL; Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Tariveranmoshabad M; Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Picton LK; Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Ravikumar P; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Li P; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Lin JX; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Escuin-Ordinas H; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Da T; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kremer SV; Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Sun AL; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Castelli S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Agarwal S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Song D; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rommel PC; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Radaelli E; Penn Vet Comparative Pathology Core, Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Young RM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Leonard WJ; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Ribas A; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. aribas@mednet.ucla.edu.; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu., June CH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cjune@upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu., Garcia KC; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. kcgarcia@stanford.edu.; Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. kcgarcia@stanford.edu.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. kcgarcia@stanford.edu.; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA. kcgarcia@stanford.edu.
Publikováno v:
Nature [Nature] 2022 Jul; Vol. 607 (7918), pp. 360-365. Date of Electronic Publication: 2022 Jun 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The British Medical Journal, 1972 Aug . 3(5825), 530-531.
Externí odkaz:
https://www.jstor.org/stable/25419903
Autor:
Santos, J.M., Heiniö, C., Cervera-Carrascon, V., Siurala, M., Quixabeira, D.C.A., de Gruijl, T., Lassus, H., Kanerva, A., Hemminki, A.
Publikováno v:
In Annals of Oncology December 2019 30 Supplement 11:xi53-xi54
Autor:
Stilpeanu, Ruxandra Ilinca1 (AUTHOR) bianca.secara@stud.umfcd.ro, Secara, Bianca Stefania1 (AUTHOR), Cretu-Stancu, Mircea2 (AUTHOR) mircea.cta@gmail.com, Bucur, Octavian1,2,3 (AUTHOR) mircea.cta@gmail.com
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11127. 18p.
Autor:
Shi, Yinghong1,2 (AUTHOR), Hao, Donglin1 (AUTHOR) haodonglin9@sina.com, Qian, Hui1,2 (AUTHOR) lstmmmlst@163.com, Tao, Zhimin1,2,3 (AUTHOR) jsutao@ujs.edu.cn
Publikováno v:
Experimental Hematology & Oncology. 10/16/2024, Vol. 13 Issue 1, p1-26. 26p.
Autor:
Birtolo, Lucia Ilaria1,2 (AUTHOR) ilaria.birtolo@irccsdebellis.it, Shahini, Endrit3 (AUTHOR) endrit.shahini@irccsdebellis.it
Publikováno v:
Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5150. 14p.
Autor:
Havunen R; TILT Biotherapeutics Ltd., 00290 Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, 00290 Helsinki, Finland., Kalliokoski R; TILT Biotherapeutics Ltd., 00290 Helsinki, Finland., Siurala M; TILT Biotherapeutics Ltd., 00290 Helsinki, Finland., Sorsa S; TILT Biotherapeutics Ltd., 00290 Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, 00290 Helsinki, Finland., Santos JM; TILT Biotherapeutics Ltd., 00290 Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, 00290 Helsinki, Finland., Cervera-Carrascon V; TILT Biotherapeutics Ltd., 00290 Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, 00290 Helsinki, Finland., Anttila M; Pathology Unit, Finnish Food Authority, 00790 Helsinki, Finland., Hemminki A; TILT Biotherapeutics Ltd., 00290 Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, 00290 Helsinki, Finland.; Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland.
Publikováno v:
Cells [Cells] 2021 Jan 27; Vol. 10 (2). Date of Electronic Publication: 2021 Jan 27.